Retatrutide Body Composition: DXA Substudy Findings
A 2025 Lancet DXA substudy measured retatrutide's dose-dependent fat mass reductions in 189 adults with type 2 diabetes. RUO educational research summary.
A 2025 Lancet DXA substudy measured retatrutide's dose-dependent fat mass reductions in 189 adults with type 2 diabetes. RUO educational research summary.